Jorma Isola - Concepedia

Author

Jorma Isola

ORCID

Also Known As

Isola Jorma, Isola, J., Isola, Jorma, J Isola, J J Isola, J. ISOLA, J. Isola, J. J. Isola, J.J. Isola, JORMA ISOLA

391

Publications

31.7K

Citations

H-Index

163

Concepts

All Affiliations

Tampere University Hospital Tampere University Helsinki University Hospital Tampere University of Applied Sciences

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	60	120	13K
2	Health Sciences	18	19	917
3	Engineering	6	6	371
4	Natural Sciences	3	3	254
5	Nursing	1	1	79

Jorma Isola

246

Publications

29.3K

Citations

H-Index

Page 1

	Year	Citations
In vivo amplification of the androgen receptor gene and progression of human prostate cancer Tapio Visakorpi, Eija Hyytinen, Pasi A. Koivisto, Nature Genetics UrologyGenitourinary CancerHormonal ReceptorVivo AmplificationProstatic Disease	1995	1.5K
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono, New England Journal of Medicine	2006	1.4K
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Ari Ristimäki, Anna Sivula, Johan Lundin, PubMed Tumor BiologyBreast OncologyCox-2 InhibitorsMedicinePathology	2002	787
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Pasi A. Koivisto, Juha Kononen, Christian Palmberg, PubMed Androgen ReceptorAr AmplificationUrologyOncologyGenitourinary Cancer	1997	725
Inherited susceptibility to uterine leiomyomas and renal cell cancer Virpi Launonen, Outi Vierimaa, Maija Kiuru, Proceedings of the National Academy of Sciences	2001	670
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab Minna Tanner, Maija Hollmén, Teemu T. Junttila, Annals of Oncology Intestinal TypeOncologyGastrointestinal OncologyMedicinePathology	2005	656
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity Lao H. Saal, Peter A. Johansson, Karolina Holm, Proceedings of the National Academy of Sciences	2007	520
Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line Péter Nagy, Elza Friedländer, Minna Tanner, Cancer Research Erbb2 Gene AmplificationBreast OncologyG Protein-coupled ReceptorReceptor Tyrosine KinaseImmunology	2005	509
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Tapio Visakorpi, Anne Kallioniemi, A C Syvänen, PubMed UrologyGenetic ChangesGenitourinary CancerTumor HeterogeneityMedicine	1995	484
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 Vilppu J. Tuominen, Sanna Ruotoistenmäki, Arttu Viitanen, Breast Cancer Research	2010	467

Page 1